Cerebrospinal Fluid Levels of Amyloid Beta 1–43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer’s Disease: A 2-Year Follow-Up Study

Introduction: Biomarkers that will reliably predict the onset of Alzheimer’s disease (AD) are urgently needed. Although cerebrospinal fluid (CSF) amyloid beta 1–42 (Aβ42), total tau, and phosphorylated tau can be used to complement the clinical diagnosis of AD, amnestic mild cognitive impairment (aM...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Aging Neurosci
Main Authors: Lauridsen, Camilla, Sando, Sigrid B., Shabnam, Adiba, Møller, Ina, Berge, Guro, Grøntvedt, Gøril R., Bakken, Inger J., Salvesen, Øyvind, Bråthen, Geir, White, Linda R.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2016
Assuntos:
Neuroscience
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4772322/
https://ncbi.nlm.nih.gov/pubmed/26973507
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2016.00030
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados